AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
AstraZeneca reported on Monday that its experimental weight-loss pill, AZD5004, licensed from China's Eccogene for up to $2 billion, was found safe and tolerable in an early-stage trial.
The study, which included 72 participants who were either healthy or had type 2 diabetes, showed side effects consistent with other GLP-1 drugs, such as nausea and vomiting. Based on these findings, AstraZeneca has advanced AZD5004 to Phase II trials focused on weight reduction in overweight and obese individuals, with completion expected by late 2025.
Unlike injectable treatments from competitors Eli Lilly and Novo Nordisk, AZD5004 is a small molecule pill that can be combined with other medications and taken with or without food, offering potential advantages for patients with additional health conditions.
AstraZeneca also shared early-stage data on other obesity drugs, AZD6234 and AZD9550, which target different hunger-related hormones and will undergo further Phase II testing through 2026.
Meanwhile, Viking Therapeutics released early trial results for its own oral obesity drug, which briefly boosted its stock before a decline.
Read next
21:30
NATO
BERLIN, Feb 22 (Reuters) - NATO is planning to build a pipeline system from Germany to Poland and the Czech Republic to ensure a rapid supply of jet fuel for fighter aircraft in the event of a war with Russia, weekly German magazine Der Spiegel reported.
17:30
OpenAI
San Francisco, CA, February 17, 2025 – OpenAI announced on Friday that its AI agent, Operator, is now available for ChatGPT Pro subscribers in a broader range of countries, including Australia, Brazil, Canada, India, Japan, Singapore, South Korea, and the United Kingdom, among others.
14:35
Peru - the roof of a food court collapsed, killing at least 3 people and injuring 74 others.
10:54
Morning Brief
Start your day informed with AnewZ Morning Brief: here are the top news stories for February 22nd, covering the latest developments you need to know.
08:19
Australia has accused China of failing to provide sufficient notice ahead of a live-fire naval drill between Australia and New Zealand, forcing airlines to alter flight paths. Defence Minister Richard Marles described the lack of communication as “disconcerting” for commercial aviation.
What is your opinion on this topic?
Leave the first comment